These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 5505394)
61. [Studies on the existence of a "natriuretic hormone" and its possible mode of action]. Kramer HJ Ann Univ Sarav Med; 1974; 21(3):140-93. PubMed ID: 4277934 [No Abstract] [Full Text] [Related]
63. Effect of sodium balance on intrarenal distribution of blood flow in normal man. Hollenberg NK; Epstein M; Guttmann RD; Conroy M; Basch RI; Merrill JP J Appl Physiol; 1970 Mar; 28(3):312-7. PubMed ID: 5414763 [No Abstract] [Full Text] [Related]
64. Failure to demonstrate the presence of a sodium transport inhibiting factor in the serum of uremic patients. Querido D; Levin V; Isaacson LC Experientia; 1975 Jun; 31(6):655-6. PubMed ID: 237776 [No Abstract] [Full Text] [Related]
65. The effect of uremic serum on granulocyte iodination capacity. Odeberg H; Olsson I; Thysell H Trans Am Soc Artif Intern Organs; 1973; 19():484-6. PubMed ID: 4722765 [No Abstract] [Full Text] [Related]
66. [Vascular reactivity of chronic uremic nonhypertensive patients]. Giordano C; Di Maio FS; Garzoni S; De Santo NG Minerva Nefrol; 1972; 19(2):128-31. PubMed ID: 4681259 [No Abstract] [Full Text] [Related]
67. Bilateral resection of superficial rat kidney cortex: effect on sodium balance. Hohenegger M; Sonntag A; Szemeredi I Experientia; 1975 Jul; 31(7):812-4. PubMed ID: 1140321 [TBL] [Abstract][Full Text] [Related]
68. The study of uremia by manipulation of blood concentrations using combinations of hollow fiber devices. Sargent JA; Gotch FA Trans Am Soc Artif Intern Organs; 1974; 20A():395-401. PubMed ID: 4450362 [No Abstract] [Full Text] [Related]
69. Identification of beta-aspartylglycine in uremic serum and its toxicity. Gejyo F; Kinoshita Y; Ito G; Ikenaka T Contrib Nephrol; 1978; 9():69-77. PubMed ID: 668390 [TBL] [Abstract][Full Text] [Related]
70. Abnormal hydroxyproline polypeptides in the urine of patients with chronic uremia. Dubovsky J; Meyer RD Nephron; 1976; 17(1):20-7. PubMed ID: 934411 [TBL] [Abstract][Full Text] [Related]
71. Different molecular forms of acid-stable trypsin inhibitor in normal and uremic plasma. Yoshida E; Sumi H; Mihara H Clin Chim Acta; 1990 Oct; 190(3):277-81. PubMed ID: 2253405 [No Abstract] [Full Text] [Related]
72. RENAL FUNCTION AFTER BURNING. SEVITT S J Clin Pathol; 1965 Jul; 18():572-8. PubMed ID: 14318721 [No Abstract] [Full Text] [Related]
73. Analytical identity of an inhibitor of sodium transport isolated from human serum and urine. Spustová V; Geryková M; Lichardus B; Dzúrik R Nephron; 1985; 39(1):18-20. PubMed ID: 3969186 [TBL] [Abstract][Full Text] [Related]
74. Further characterization and evidence for a precursor in the formation of plasma antinatriferic factor. Gruber KA; Buckalew VM Proc Soc Exp Biol Med; 1978 Dec; 159(3):463-7. PubMed ID: 733812 [No Abstract] [Full Text] [Related]
75. Endogenous cardiotonic steroids in kidney failure: a review and an hypothesis. Hamlyn JM; Manunta P Adv Chronic Kidney Dis; 2015 May; 22(3):232-44. PubMed ID: 25908473 [TBL] [Abstract][Full Text] [Related]
76. Natriuretic hormones, endogenous ouabain, and related sodium transport inhibitors. Hamlyn JM Front Endocrinol (Lausanne); 2014; 5():199. PubMed ID: 25520702 [TBL] [Abstract][Full Text] [Related]